Crystalline forms of wild type kit inhibitors
WO2025255295A1PCT designated stage Publication Date: 2025-12-11BLUEPRINT MEDICINES CORP
2 Cites 0 Cited by
Patent Information
- Application Number
- PCT/US2025/032372
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-06-06
- Filing Date
- 2025-06-05
- Publication Date
- 2025-12-11
Smart Images
Figure US2025032372_11122025_PF_FP_ABST
Abstract
Various crystalline forms of Compound (I) represented by the following formula are disclosed. Pharmaceutical compositions comprising the same, methods of treating disorders and disorders mediated by wild type c-kit kinase using the same, and methods for making the crystalline forms of Compound (I) are also disclosed.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Certain chemical entities, compositions, and methods
WO2023212612A2
N-phenyl-pyrazolo[1,5-a]pyridine-3-carboxamide derivatives as wild type c-kit kinase inhibitors for the treatment of urticaria
WO2024118887A1